7 results match your criteria: "Medical School of the City University of New York[Affiliation]"
To characterize cervical cancer screening knowledge, beliefs, behaviors, and sociodemographic factors among women aged 25-45 years who access and utilize prenatal care services in Nairobi, Kenya. A descriptive cross-sectional design using a convenience sample of pregnant women receiving prenatal health services at a public and a private hospital in Nairobi, Kenya. Constructs from the Health Belief Model (HBM) guided the design, interpretation of the results, and recommendations.
View Article and Find Full Text PDFUnlabelled: Trace elements such as cadmium, arsenic, zinc or selenium increase or decrease risk of a wide range of human diseases. Their levels in toenails may provide a measure of mid-term intake of trace elements for studies in humans. However, in biologically and clinically aggressive diseases as pancreatic cancer, the progression of the disease could modify such concentrations and produce reverse causation bias.
View Article and Find Full Text PDFRisk factors for inflammatory and non-inflammatory breast cancer in North Africa.
Breast Cancer Res Treat
November 2020
Medical School of the City University of New York, New York, USA.
Article Synopsis
- The study investigated various risk factors associated with inflammatory breast cancer (IBC) through a case-control analysis involving 267 IBC cases alongside matched non-IBC cases and controls across Egypt, Tunisia, and Morocco.
- Findings indicated that a recent livebirth and diabetes were linked to an increased risk of IBC, while certain factors such as family history of breast cancer and low socioeconomic status elevated the risk for both IBC and non-IBC.
- The research highlights potential new risk factors for IBC, suggesting that confirming these associations could improve understanding and prevention of this aggressive cancer type.
Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
Breast Cancer Res Treat
July 2019
Medical School of the City University of New York, New York, NY, USA.
Article Synopsis
- - The study analyzed the clinico-pathologic and mammographic features of 267 inflammatory breast cancer (IBC) cases and 274 matched non-IBC cases across Egypt, Tunisia, and Morocco from 2009 to 2015, emphasizing the subjective nature of IBC diagnosis based on clinical signs like erythema.
- - Results revealed significant differences between IBC and non-IBC cases, including hormone receptor status, presence of erythema, and mammographic findings, with higher percentages of IBC patients meeting expert definitions of the condition.
- - The findings suggest that using standardized medical photographs and expert reviews is crucial to improve the reliability of IBC diagnoses, highlighting the need for clear clinical guidelines in identifying this aggressive cancer type
Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
Breast Cancer Res Treat
June 2019
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Purpose: Inflammatory breast cancer (IBC) rates increased in the United States before the turn of the twenty-first century. We examine trends by estrogen receptor (ER) status since then.
Methods: Using data from the Surveillance, Epidemiology, and End Results (SEER) program for years 2001-2015, we calculated age-adjusted incidence rates for IBC (defined by AJCC TNM category T4d, extent of disease codes, and morphology code 8530) by ER status, which was imputed if unknown, among women aged 25-84 years.
Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.
Breast Cancer Res Treat
February 2019
Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Purpose: While racial disparities in inflammatory breast cancer (IBC) incidence are fairly well documented, with black women having significantly higher rates compared to white women; less is known about whether IBC prognosis differs by race/ethnicity. Therefore, the objective of this study was to assess racial/ethnic disparities in survival among women diagnosed with IBC in the Michigan Cancer Surveillance Program (MCSP) from 1998 to 2014.
Methods: We examined the frequency and percentage of breast cancer cases coded to the various IBC codes in the MCSP registry over the study period.